Kinfo
Tuhura Biosciences Inc. logo

Tuhura Biosciences Inc.

KTRANASDAQHealthcare·US · USD
$1.93
-0.05 (-2.53%)
Prices as of October 8, 2026 · market closed

Price

Key statistics

Valuation
Market cap106.74M USD
Enterprise value0.00 USD
Trailing P/E0.00
Forward P/E-0.57
PEG ratio0.00
Price / sales0.00
Price / book0.00
Profitability
Gross margin0.00%
Operating margin0.00%
Profit margin0.00%
Return on assets-137.07%
Return on equity-226.27%
Income (TTM)
Revenue0.00 USD
Gross profit0.00 USD
EBITDA0.00 USD
Net income-8.50M USD
Diluted EPS$0.00
Rev. growth (YoY)0.00%
Balance sheet
Total cash0.00 USD
Total debt0.00 USD
Debt / equity0.00
Current ratio2.45
Book value / share$0.00
Cash flow (TTM)
Operating cash flow-8.21M USD
Levered free cash flow-8.50M USD
Shares & price
Shares outstanding55.30M
Float0.00
Held by institutions0.00%
Beta0.00
50-day MA$0.00
200-day MA$0.00
52-week high$3.43
52-week low$0.41
Earnings (EPS)
DateEst.ActualSurprise2023-11-12—-1.83—2023-09-18-67.55-68.25−1.04%2023-05-11-122.50-67.90+44.57%
About Tuhura Biosciences Inc.

Tuhura Biosciences Inc. is a biotechnology company involved in discovering and developing innovative therapies to address unmet medical needs. The company's primary function is to enhance the quality of life for patients by focusing on cutting-edge research and leveraging advanced technologies in drug discovery and development. Tuhura Biosciences operates at the intersection of healthcare and technology, influencing the biotechnology and pharmaceutical industries. Its research initiatives are geared towards understanding complex biological systems and translating this knowledge into actionable medical interventions. By harnessing the power of data-driven insights and precision medicine, Tuhura Biosciences plays a significant role in the market, contributing to the advancement of personalized healthcare solutions and offering potential breakthroughs in the treatment landscape for various diseases. Its presence underscores the growing momentum in the biosciences sector, as companies strive to bring new therapies from the laboratory to the clinic, ultimately aiming to improve patient outcomes globally.

Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Robert E. Hoffman B.B.A., CPA
Employees
1
Headquarters
San Diego, CA, United States

Frequently asked questions about Tuhura Biosciences Inc.